All Clinical Trials

A listing of 23116 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Healthy Participants Needed (Colonoscopy + Cancer Screening)

Recruiting

Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.

Conditions:

Healthy

Healthy Volunteers

Healthy Subjects

Healthy Volunteer

Healthy Participants

Learn More

Featured Therapy

Unique Treatment for High Blood Pressure

Worried about high blood pressure? Think beyond typical high blood pressure treatments.

People who may be candidates for this procedure:

• Are at least 18 years old
• Have been unable to manage their high blood pressure with medications or lifestyle changes alone¹

Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.

¹ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.

Conditions:

High Blood Pressure

High Blood Pressure (& [Essential Hypertension])

High Blood Pressure (Hypertension).

Hypertension

Essential Hypertension

Learn More

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

Featured Trial

Discover Clinical Trials In Your Area (Compensation Provided)

Recruiting

Clinical trials in your area are actively enrolling — and they compensate you for your time. Finding the right one has never been easier.

- Matched to trials in your zip code
- Compensation for time & travel
- Free or low-cost treatments available
- No experience or medical background needed
- Takes just 30 seconds to see if you qualify

Conditions:

Healthy

Healthy Volunteers

Learn More

Featured Offer

Lose 20% of Body Weight With GLP-1's

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).

Get $50 off your first order using promo code: policy-lab-50

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

COVID-19 Vaccine Clinical Trial (Compensation Provided)

Recruiting

Healthy adults ages 50-64 may qualify. You may be eligible if you haven’t received a COVID-19 vaccine and haven’t had COVID-19 in the last 90 days.

Qualified participants may receive compensation for time and travel.

Conditions:

Healthy

Vaccine

COVID19

COVID-19

COVID-19 Vaccine

Learn More

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

NCT06140836

Recruiting

The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: Local Institution - 0136, Augusta, Georgia +143 locations

Local Institution - 0136, Augusta, Georgia

Local Institution - 0221, Des Moines, Iowa

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Local Institution - 0217, Brooklyn, New York

Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York

Laura and Isaac Perlmutter Cancer Center, New York, New York

Local Institution - 0127, Syracuse, New York

Local Institution - 0214, Tacoma, Washington

Local Institution - 0061, Milwaukee, Wisconsin

Local Institution - 0092, Ciudad autónoma de Buenos Aires, Buenos Aires

Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires

Local Institution - 0091, ABB, Ciudad Autónoma De Buenos Aires

Local Institution - 0106, Buenos Aires, Not set

Local Institution - 0207, Buenos Aires, Not set

Instituto Oncológico de Córdoba, Córdoba, Not set

Local Institution - 0041, Wien, Not set

Local Institution - 0073, Belo Horizonte, Minas Gerais

Local Institution - 0033, Porto Alegre, Rio Grande Do Sul

Local Institution - 0034, Porto Alegre, Rio Grande Do Sul

Local Institution - 0029, Barretos, São Paulo

Local Institution - 0209, Sao Paulo, São Paulo

Local Institution - 0147, Sao Paulo, São Paulo

Local Institution - 0037, São José do Rio Preto, São Paulo

Local Institution - 0098, Rio de Janeiro, Not set

Local Institution - 0108, Rio de Janeiro, Not set

Local Institution - 0032, São Paulo, Not set

Local Institution - 0114, São Paulo, Not set

Local Institution - 0002, Toronto, Ontario

Local Institution - 0123, Trois-Rivières, Quebec

Fundacion Arturo Lopez Perez (FALP), Santiago, Región Metropolitana De Santiago

Oncocentro Apys, Viña del Mar, Valparaíso

Local Institution - 0168, Beijing, Beijing

Local Institution - 0185, Chongqing, Chongqing

Local Institution - 0192, Fuzhou, Fujian

Local Institution - 0169, Xiamen, Fujian

Local Institution - 0180, Guangzhou, Guangdong

Local Institution - 0194, Nanning, Guangxi

Local Institution - 0171, Harbin, Heilongjiang

Local Institution - 0166, Zhengzhou, Henan

Local Institution - 0181, Wuhan Shi, Hubei

Local Institution - 0203, Wuhan, Hubei

Local Institution - 0184, Changsha, Hunan

Local Institution - 0165, Changsha, Hunan

Local Institution - 0193, Nanjing, Jiangsu

Local Institution - 0202, Nanchang, Jiangxi

Local Institution - 0178, Changchun, Jilin

Local Institution - 0183, Xi'an, Shaanxi

Local Institution - 0186, Jinan, Shandong

Local Institution - 0205, Linyi, Shandong

Local Institution - 0164, Shanghai, Shanghai

Local Institution - 0179, Shanghai, Shanghai

Local Institution - 0170, Chengdu, Sichuan

Local Institution - 0177, Chengdu, Sichuan

Local Institution - 0204, Kunming, Yunnan

Local Institution - 0206, Hangzhou, Zhejiang

Local Institution - 0175, Hangzhou, Zhejiang

Nouvel Hôpital Civil (NHC), Strasbourg, Alsace

CHU Bordeaux Haut-Leveque, Pessac, Aquitaine

Centre Georges François Leclerc, Dijon, Côte-d'Or

CHU Charles Nicolle, Rouen, Haute-Normandie

Chu Grenoble Alpes, La Tronche, Isère

Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes, Saint-Herblain, Loire-Atlantique

Centre Hospitalier Lyon Sud, Pierre-Bénite, Rhône

Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set

Klinikum Esslingen, Esslingen, Baden-Württemberg

Klinikum Würzburg Mitte, Wuerzburg, Bayern

Pius Hospital Oldenburg, Oldenburg, Niedersachsen

Evangelische Lungenklinik Berlin, Berlin, Not set

Local Institution - 0035, Dresden, Not set

Asklepios Klinik Gauting GmbH, Gauting, Not set

Lungenfachklinik Immenhausen, Immenhausen, Not set

Universitaetsklinikum Koeln, Köln, Not set

Marienhaus Klinikum Mainz, Mainz, Not set

University Hospital of Patras, Patras, Achaḯa

Local Institution - 0153, Athens, Attikí

Local Institution - 0155, Chaidari, Attikí

"Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki, Kentrikí Makedonía

Országos Korányi Pulmonológiai Intézet, Budapest, Not set

All India Institute of Medical Sciences, New Delhi, Delhi

Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi

Hemato Oncology Clinic, Ahmedabad, Gujarat

HCG Aastha Cancer Centre, Ahmedabad, Gujarat

Local Institution - 0117, Gurgaon, Haryana

Artemis hospital, Gurugram, Haryana

Manipal Hospitals, Bengaluru, Karnataka

Local Institution - 0219, Thiruvananthapuram, Kerala

Local Institution - 0065, Mumbai, Maharashtra

Local Institution - 0048, Mumbai, Maharashtra

Grant Medical Foundation - Ruby Hall Clinic, Pune, Maharashtra

Sahyadri Super Speciality Hospital, Pune, Maharashtra

Local Institution - 0220, Hyderabad, Telangana

Cro-Irccs, Aviano, Friuli-Venezia Giulia

Local Institution - 0152, Milan, Lombardia

Fondazione IRCCS San Gerardo dei Tintori, Monza, Lombardia

A.O.R.N. Ospedale dei Colli - Monaldi V., Naples, Napoli

Local Institution - 0148, Rome, Roma

Nagoya University Hospital, Nagoya, Aichi

National Cancer Center Hospital East, Kashiwa, Chiba

Local Institution - 0174, Matsuyama-shi, Ehime

Hokkaido University Hospital, Sapporo, Hokkaido

Kanagawa cancer center, Yokohama, Kanagawa

Sendai Kosei Hospital, Sendai, Miyagi

Tokyo Metropolitan Komagome Hospital, Bunkyo ku, Tokyo

Tottori University Hospital, Yonago, Tottori

Local Institution - 0195, Fukuoka, Not set

Osaka City General Hospital, Osaka, Not set

Osaka International Cancer Institute, Osaka, Not set

Tokyo Metropolitan Police Hospital, Tokyo, Not set

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]

Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do

Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]

Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0223, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur

Local Institution - 0237, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur

Local Institution - 0222, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur

Local Institution - 0226, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur

Local Institution - 0224, Putrajaya, Wilayah Persekutuan Kuala Lumpur

Amsterdam UMC, locatie VUmc, Amsterdam, Noord-Holland

Local Institution - 0215, Groningen, Not set

Local Institution - 0187, Lublin, Lubelskie

Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie, Olsztyn, Warmińsko-mazurskie

SC Memorial Healthcare International SRL, Bucharest, București

Institutul Oncologic Bucuresti, Bucharest, București

Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj

Institutul Oncologic Cluj, Cluj, Not set

S.C. Centrul de Oncologie Euroclinic S.R.L., Iași, Not set

CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [La Coruña]

CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]

Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De

H.R.U Málaga - Hospital General, Málaga, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Hospital Universitari i Politecnic La Fe, València, Not set

Kantonspital Baden, Baden, Aargau

Ankara Bilkent Şehir Hastanesi, Yenimahalle, Ankara

Adana Medical Park Seyhan Hastanesi, Adana, Not set

Sbü Gülhane Eğitim Ve Araştirma Hastanesi, Ankara, Not set

Medipol Mega Universite Hastanesi, Istanbul, Not set

T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Istanbul, Not set

VM Medical Park Pendik Hospital, Istanbul, Not set

Sakarya Training and Research Hospital, Sakarya, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)

NCT06924970

Recruiting

The main purpose of this study is to compare the effect of tebapivat versus placebo on anemia and to detect a dose-response for hemoglobin (Hb) response in participants with SCD.

Gender:

ALL

Ages:

16 years and above

Trial Updated:

08/18/2025

Locations: MedStar Washington Hospital Center, Washington, District of Columbia +2 locations

Conditions: Sickle Cell Disease

Learn More ›

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

NCT06545955

Recruiting

The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadofaragene firadenovec showed that 55 (53.4%) of 103 subjects with CIS ± high-grade Ta/T1 achieved a complete response (CR) at 3 months. In this trial, the safety and efficacy of intravesical instillation of nadofaragene firadenovec alone or in combination with chemotherapy or immunotherapy will be evaluated in participants with NMIBC CIS (± high-grade Ta/T1).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: Urology Associates of Central California, Fresno, California +17 locations

Conditions: Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Learn More ›

IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack

NCT06139328

Recruiting

This study is open to adults aged 18 and over who have just had a heart attack. The purpose of this study is to find out whether a medicine called BI 765845 helps people who have had a heart attack. The investigators also want to test how well different doses of BI 765845 work and how they are tolerated by people who have had a heart attack. Participants are randomly assigned to receive either BI 765845 or placebo. Placebo treatments look like BI 765845 treatments but do not contain any medicin... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: University of Arizona, Tucson, Arizona +103 locations

University of Arizona, Tucson, Arizona

Flourish Research - Los Angeles (Covina) Clinical Research, Covina, California

Colorado Heart and Vascular PC, Golden, Colorado

University of Florida Health Jacksonville, Jacksonville, Florida

Southern Illinois University School of Medicine, Springfield, Illinois

Brigham and Women's Hospital, Boston, Massachusetts

Allina Health System, Minneapolis, Minnesota

Hackensack University Medical Center, Hackensack, New Jersey

University at Buffalo, The State University of New York, Buffalo, New York

Moses H. Cone Memorial Hospital, Greensboro, North Carolina

University of Tennessee, Knoxville, Tennessee

The University of Texas Health Science Center at Houston, Houston, Texas

South Western Sydney Local Health District, Liverpool, New South Wales

The Prince Charles Hospital, Chermside, Queensland

The Northern Hospital, Epping, Victoria

Fiona Stanley Hospital, Murdoch, Western Australia

University of Calgary, Calgary, Alberta

University of Alberta Hospital (University of Alberta), Edmonton, Alberta

St. Boniface Hospital, Winnipeg, Manitoba

Hamilton General Hospital, Hamilton, Ontario

University of Ottawa Heart Institute, Ottawa, Ontario

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec

IUCPQ (Laval University), Quebec, Not set

University Hospital at St. Anna, Brno, Not set

University Hospital Brno, Brno, Not set

General University Hospital, Prague 2, Not set

Charite Universitätsmedizin Berlin KöR, Berlin, Not set

St. Johannes Hospital Dortmund, Dortmund, Not set

Städtisches Klinikum Dresden, Dresden, Not set

Universitätsklinikum Frankfurt, Frankfurt, Not set

Universitätsklinikum Freiburg, Freiburg, Not set

Medizinische Hochschule Hannover, Hannover, Not set

Universitätsklinikum Heidelberg, Heidelberg, Not set

Asklepios Klinik Langen-Seligenstadt GmbH, Langen, Not set

Universität Leipzig, Leipzig, Not set

Helios Herzzentrum Leipzig GmbH, Leipzig, Not set

Klinikum der Stadt Ludwigshafen am Rhein GmbH, Ludwigshafen, Not set

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Not set

Krankenhaus der Barmherzigen Brüder Trier, Trier, Not set

Universitätsklinikum Ulm, Ulm, Not set

Semmelweis University, Budapest, Not set

University of Pecs, Pecs, Not set

Zala County Hospital, Zalaegerszeg, Zalaegerszeg, Not set

Ospedale San Paolo-Bari-18924, Bari, Not set

Fond. Poliambulanza Istituto, Brescia, Not set

A.O. "S. Anna e San Sebastiano", Caserta, Not set

Azienda Ospedaliera Cannizzaro, Catania, Not set

Azienda Ospedaliera Universitaria Arcispedale Sant'Anna, Cona (FE), Not set

Azienda Ospedaliera San Martino, Genova, Not set

Osp. Pediatrico Apuano Pasquinucci, Massa, Not set

A.O. San Gerardo di Monza, Monza, Not set

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo, Not set

Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello, Palermo, Not set

Ospedale di Rivoli (A.S.L. TO3), Rivoli (TO), Not set

A.O. San Camillo Forlanini, Roma, Not set

AOU Policlinico Umberto I, Roma, Not set

Ospedale Mauriziano di Torino, Torino, Not set

Kasugai Municipal Hospital, Aichi, Kasugai, Not set

NHO Mito Medical Center, Ibaraki, Higashiibaraki-gun, Not set

Yokohama City University Hospital, Kanagawa, Yokohama, Not set

Tohoku University Hospital, Miyagi, Sendai, Not set

Kawasaki Medical School Hospital, Okayama, Kurashiki, Not set

Juzenkai The Sakakibara Heart Institute of Okayama, Okayama, Okayama, Not set

Kindai University Hospital, Osaka, Osakasayama, Not set

Sakurabashi Watanabe Advanced Healthcare Hospital, Osaka, Osaka, Not set

Tokushima University Hospital, Tokushima, Tokushima, Not set

Keio University Hospital, Tokyo, Shinjuku-ku, Not set

Dong-A University Hospital, Busan, Not set

Chonnam National University Hospital, Gwangju, Not set

Seoul National University Hospital, Seoul, Not set

Hanyang University Medical Center, Seoul, Not set

Christchurch Public Hospital, Christchurch, Not set

Auckland City Hospital, Grafton / Auckland, Not set

American-Polish Heart Clinic, Lesser Poland Cardiovascular Centre, Chrzanow, Not set

University Hospital in Krakow, Krakow, Not set

Independent Public Health Care in Myszkow, Myszkow, Not set

University Clinical Hospital in Opole, Opole, Not set

Independent Public Health Care Center of the Ministry of the Interior in Rzeszow, Rzeszow, Not set

American Heart of Poland Sp. z o.o.-Tychy-44644, Tychy, Not set

Silesian Center for Heart Diseases, Zabrze, Not set

National University Hospital-Singapore-42005, Singapore, Not set

National Heart Centre Singapore, Singapore, Not set

Tan Tock Seng Hospital, Singapore, Not set

Changi General Hospital, Singapore, Not set

Sengkang General Hospital, Singapore, Not set

Khoo Teck Puat Hospital, Singapore, Not set

Cardiovascular Diseases institute of Central Slovakia, Banska Bystrica, Not set

National Institute of Cardiovascular Diseases, Bratislava, Not set

Cardiocenter Nitra, s.r.o, Nitra, Not set

Hospital Santa Creu i Sant Pau, Barcelona, Not set

Hospital Vall d'Hebron, Barcelona, Not set

Hospital Universitario Virgen de la Arrixaca, El Palmar, Not set

Hospital General Universitario Gregorio Marañón, Madrid, Not set

Hospital La Paz, Madrid, Not set

Complexo Hospitalario Universitario De Santiago, Santiago de Compostela, Not set

Hospital Virgen Macarena, Sevilla, Not set

Complejo Hospitalario Universitario de Vigo, Vigo, Not set

NCKUH, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Golden Jubilee National Hospital, Clydebank, Not set

Leeds General Infirmary, Leeds, Not set

St Bartholomew's Hospital, London, Not set

Wythenshawe Hospital, Manchester, Not set

Freeman Hospital, Newcastle upon Tyne, Not set

Conditions: Myocardial Infarction

Learn More ›

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors

NCT06188208

Recruiting

A FIH study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of VVD-130850, as single agent and in combination with checkpoint inhibition, in participants with advanced solid and hematologic tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: California Research Institute, Los Angeles, California +19 locations

Conditions: Advanced Solid Tumors, Advanced Hematologic Tumors

Learn More ›

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

NCT05968326

Recruiting

The purpose of this study is to evaluate the efficacy and safety of adjuvant autogene cevumeran plus atezolizumab and modified leucovorin, 5-fluorouracil (5-FU), irinotecan, and oxaliplatin (mFOLFIRINOX) versus mFOLFIRINOX alone in participants with resected pancreatic ductal adenocarcinoma (PDAC) who have not received prior systemic anti-cancer treatment for PDAC and have no evidence of disease after surgery.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: USC Norris Comprehensive Cancer Center, Los Angeles, California +84 locations

USC Norris Comprehensive Cancer Center, Los Angeles, California

University of California Los Angeles, Los Angeles, California

USC Norris Cancer Center, Newport Beach, California

University of California, San Francisco (UCSF), San Francisco, California

St. Francis Hospital and Medical Center, Hartford, Connecticut

Smilow Cancer Center, New Haven, Connecticut

Yale Cancer Center, New Haven, Connecticut

Smilow Cancer Hospital Care Center at Trumbull, Trumbull, Connecticut

Northwestern Memorial Hospital, Chicago, Illinois

Indiana University Health Melvin & Bren Simon Cancer Center, Indianapolis, Indiana

University of Kentucky Medical Center, Lexington, Kentucky

Harvard Medical School - Massachusetts General Hospital (MGH) - Cancer Center, Boston, Massachusetts

Boston Medical Center (BMC) - Cancer Care Center, Boston, Massachusetts

Henry Ford Health System, Detroit, Michigan

University of Nebraska, Omaha, Nebraska

Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge, New Jersey

Memorial Sloan Kettering Cancer Center, Middletown, New Jersey

Memorial Sloan Kettering Cancer Center at Bergen, Montvale, New Jersey

Memorial Sloan Kettering Cancer Center - Commack, Commack, New York

Memorial Sloan Kettering Cancer Center at Westchester, Harrison, New York

Northwell Health, Lake Success, New York

NYU Langone Health, New York, New York

Mount SInai Medical Center, New York, New York

Columbia University Medical Center, New York, New York

MEETH-LHH Northwell Health Cancer Clinical Trials Office at MEETH-LHH, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Memorial Sloan Kettering Cancer Center at Nassau, Uniondale, New York

Duke Cancer Institute, Durham, North Carolina

University of Cincinnati Cancer Institute, Cincinnati, Ohio

Rhode Island Hospital, Providence, Rhode Island

Miriam Hospital, Providence, Rhode Island

Fred Hutchinson Cancer Research Center, Seattle, Washington

ULB Hôpital Erasme, Brussels, Not set

Antwerp University Hospital, Edegem, Not set

AZ Maria Middelares, Gent, Not set

Universitair Ziekenhuis Gent, Gent, Not set

UZ Leuven, Leuven, Not set

St Michael Hospital, Toronto, Ontario

Princess Margaret Cancer Center, Toronto, Ontario

Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec

Jewish General Hospital, Montreal, Quebec

Centre Hospitalier Régional Universitaire de Lille, Lille, Not set

Centre Leon Berard, Lyon, Not set

Institut Paoli Calmettes, Marseille, Not set

Institut de Cancérologie de Lorraine, Vandoeuvre-Les-Nancy, Not set

Gustave Roussy, Villejuif, Not set

Charite-Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK), Berlin, Not set

Universitaetsklinikum der Ruhr-Universitaet Bochum (UKRUB), Bochum, Not set

Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Not set

Universitätsklinikum Essen, Essen, Not set

Krankenhaus Nordwest GmbH, Frankfurt, Not set

Universitätsklinikum Hamburg-Eppendorf, Hamburg, Not set

Universitaetsklinikum Heidelberg, Heidelberg, Not set

Universitaetsklinikum Koeln, Koeln, Not set

Universitaetsklinikum Tuebingen, Tuebingen, Not set

Universitätsklinikum Ulm, Klinik für Innere MedizinInnere Medizin III Studienzentrale, Ulm, Not set

National Cancer Center (NCC) Hospital - Center for Liver and Pancreatobiliary Cancer, Goyang-si, Not set

CHA Bundang Medical Center, Gyeonggi-do, Not set

The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital), Seocho, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

Severance Hospital - Yonsei Cancer Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

University of Ulsan College of Medicine - Asan Medical Center (AMC) - Asan Cancer Center (ACC), Songpa-gu, Not set

Amsterdam UMC Location VUMC, Amsterdam, Not set

Erasmus MC, Rotterdam, Not set

Hospital Universitario Central de Asturias, Oviedo, Asturias

Institut Catala d?Oncologia Hospital Germans Trias i Pujol, Badalona, Barcelona

Hospital Regional Universitario de Malaga, Málaga, Malaga

Clinica Universitaria de Navarra (CUN), Pamplona/iruña, Navarra

Hospital Universitario Vall d Hebron, Barcelona, Not set

Hospital General Universitario Gregorio Marañon, Madrid, Not set

Clinica Universitaria de Navarra de Madrid;Servicio de Hepatologia, Madrid, Not set

Hospital Universitario Ramon y Cajal, Madrid, Not set

Hospital Universitario 12 De Octubre, Madrid, Not set

Centro Integral Oncológico Clara Campal Ensayos Clínicos START, Madrid, Not set

Sahlgrenska Universitetssjukhuset, Gothenburg, Not set

Karolinska Universitetssjukhuset, Solna, Not set

Belfast City Hospital, Belfast, Not set

University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set

Addenbrookes Hospital, Cambridge, Not set

Royal Liverpool University Hospital, Liverpool, Not set

Barts Health NHS Trust, London, Not set

Guys Hospital, London, Not set

Hammersmith Hospital, London, Not set

University College London Cancer Institute, London, Not set

Conditions: Adenocarcinoma, Pancreatic Ductal

Learn More ›

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

NCT06116786

Recruiting

The purpose of this study is to determine a safe and tolerable dose(s) of JNJ-86974680 for further research in combination with cetrelimab and radiation therapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: Hackensack University Medical Center, Hackensack, New Jersey +12 locations

Conditions: Carcinoma, Non-small-Cell Lung

Learn More ›

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

NCT05620407

Recruiting

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population.

Gender:

ALL

Ages:

Between 18 years and 75 years

Trial Updated:

08/18/2025

Locations: Local Institution - 0237, Searcy, Arkansas +206 locations

Local Institution - 0237, Searcy, Arkansas

UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla, California

Local Institution - 0241, San Diego, California

Rheumatology Center of San Diego, San Diego, California

East Bay Rheumatology Medical Group, Inc, San Leandro, California

Providence Saint John's Medical Foundation, Santa Monica, California

Clinical Research of West Florida, Inc. (Clearwater), Clearwater, Florida

UF Health Deerwood Park, Jacksonville, Florida

Life Clinical Trials, Margate, Florida

Nuline Clinical Trial Center, Oakland Park, Florida

Local Institution - 0239, Plant City, Florida

Emory University School of Medicine- Grady Campus, Atlanta, Georgia

Atlanta Research Center for Rheumatology, Marietta, Georgia

Greater Chicago Specialty Physicians - Orland Park, Orland Park, Illinois

Local Institution - 0041, Skokie, Illinois

Local Institution - 0231, New Orleans, Louisiana

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

University of Massachusetts Chan Medical School, Worcester, Massachusetts

AA Medical Research Center-Grand Blanc, Grand Blanc, Michigan

Mayo Clinic in Rochester, Minnesota, Rochester, Minnesota

Local Institution - 0200, Las Vegas, Nevada

Local Institution - 0216, Las Vegas, Nevada

The Valley Hospital, Inc., Paramus, New Jersey

Joseph S. and Diane H. Steinberg Ambulatory Care Center, Brooklyn, New York

Irving Goldman Family Care Center, Great Neck, New York

Hospital for Special Surgery, New York, New York

Columbia University Medical Center, New York, New York

SUNY Upstate Medical University, Syracuse, New York

Local Institution - 0178, Charlotte, North Carolina

University of Cincinnati Medical Center, Cincinnati, Ohio

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma

Temple University Hospital, Philadelphia, Pennsylvania

West Penn Allegheny Health, Pittsburgh, Pennsylvania

Local Institution - 0081, Charleston, South Carolina

Hope Health, Florence, South Carolina

Local Institution - 0228, Florence, South Carolina

West Tennessee Research Institute, Jackson, Tennessee

Austin Regional Clinic, Austin, Texas

Local Institution - 0001, Colleyville, Texas

Texas Arthritis Center, El Paso, Texas

Biopharma Informatic, LLC, Katy, Texas

Baylor Scott & White Medical Center - Temple, Temple, Texas

Spectrum Medical, Inc., Danville, Virginia

Sanatorio Guemes, Ciudad de Buenos Aires, Buenos Aires

Hospital El Cruce, Florencio Varela, Buenos Aires

Hospital Italiano de La Plata, La Plata, Buenos Aires

Centro de Investigacion Pergamino S.A., Pergamino, Buenos Aires

Hospital Universitario Austral, Pilar, Buenos Aires

Centro de Investigaciones San Miguel, San Miguel, Buenos Aires

CER medical Institute, Quilmes, Ciudad Autónoma De Buenos Aires

Centro de Investigaciones Médicas Tucuman, SAN M. DE Tucuman, Tucumán

Centro Integral de Reumatologia, San Miguel de Tucumán, Tucumán

Local Institution - 0141, Río Cuarto, Not set

Liverpool Hospital, Liverpool, New South Wales

BJC Health, Paramatta, New South Wales

Rheumatology Research Unit, Maroochydore, Queensland

Austin Health - Repatriation Hospital, Ivanhoe, Victoria

RK Will Pty Ltd, Victoria Park, Western Australia

CEDOES, Vitória, Espírito Santo

Local Institution - 0232, Recife, Pernambuco

Hospital Bruno Born, Lajeado, Rio Grande Do Sul

Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul

Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul

Instituto de Pesquisa e Ensino em Saúde - IPES, Porto Velho, Rondônia

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo

Local Institution - 0095, Santo André, São Paulo

Centro Multidisciplinar de Estudos Clinicos, Sao Bernardo do Campo, São Paulo

Local Institution - 0033, Curitiba, Not set

Hospital São Lucas de Copacabana, Rio de Janeiro, Not set

Hospital Alemao Oswaldo Cruz, São Paulo, Not set

Hospital 9 De Julho, São Paulo, Not set

CEPIC - Centro Paulista de Investigação Clínica, São Paulo, Not set

Diagnostic Consultative Centre (DCC) - Foкus 5, Sofia, Sofia (stolitsa)

University Hospital Kaspela Clinic of Rheumatology, Plovdiv, Not set

Diagnostic Consultative Centre 1 Ruse, Ruse, Not set

Local Institution - 0214, Sofia, Not set

IC La Serena Research, La Serena, Coquimbo

Local Institution - 0099, Valdivia, Los Ríos

Estudios Clinicos CTR, Santiago, Región Metropolitana De Santiago

Biomedica Research Group, Santiago, Región Metropolitana De Santiago

Estudios Clinicos Limitada, Santiago, Región Metropolitana De Santiago

Local Institution - 0044, Santiago, Región Metropolitana De Santiago

Local Institution - 0098, Santiago, Región Metropolitana De Santiago

Pontificia Universidad Catolica de Chile, Santiago, Región Metropolitana De Santiago

Clínica Ensenada, Santiago, Región Metropolitana De Santiago

Local Institution - 0153, Santiago, Not set

INREA s.r.o., Ostrava, Ostrava Město

Revmatologicky ustav, Praha 2, Not set

General Hospital of Athens Hippokratio, Athens, Attikí (Region)

General Hospital of Athens "Laiko", Athens, Attikí

University General Hospital of Larissa, Larissa, Thessalía

Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya

Békés Vármegyei Központi Kórház Pándy Kálmán Tagkórház, Gyula, Békés

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ, Szeged, Csongrád

Vital Medical Center, Veszprem, Veszprém City

Local Institution - 0197, New Delhi, Delhi

Local Institution - 0234, Ahmedabad, Gujarat

Local Institution - 0209, Ahmedabad, Gujarat

Ratan Multi-Speciality Hospital, Ahmedabad, Gujarat

Sushruta Multispeciality Hospital & Research Centre, Hubli, Karnataka

JSS Hospital, Mysore, Karnataka

Jasleen Hospital, Nagpur, Maharashtra

Christian Medical College Vellore, Vellore, Tamil Nadu

Local Institution - 0204, Vellore, Tamil Nadu

Local Institution - 0235, Hyderabad, Telangana

Krishna Institute of Medical Science, Secundarabad, Telangana

Koujunkai Daido Clinic, Nagoya, Aichi

Local Institution - 0156, Nagoya, Aichi

Fujita Health University, Toyoake, Aichi

Local Institution - 0086, Eiheiji-cho,Yoshida-gun, Fukui

University of Occupational and Enviromental Health, Kitakyushu, Fukuoka

National Hospital Organization Asahikawa Medical Center, Asahikawa, Hokkaido

Hokkaido University Hospital, Sapporo, Hokkaido

Kagawa University Hospital, Kita, Kagawa

Kitasato University Hospital, Sagamihara, Kanagawa

Yokohama City University Hospital, Yokohama, Kanagawa

Tohoku University Hospital, Sendai-shi, Miyagi

Sasebo Chuo Hospital, Sasebo, Nagasaki

Saitama Medical Center, Kawagoe, Saitama

Dokkyo Medical University Hospital, Shimotsuga, Tochigi

Juntendo University Hospital, Bunkyo-ku, Tokyo

Tokyo Medical and Dental University Hospital, Bunkyo-ku, Tokyo

Toho University Ohashi Medical Center, Meguro-ku, Tokyo

Center Hospital of the National Center for Global Health and Medicine, Shinjyuku-ku, Tokyo

Toyama University Hospital, Toyoma, Toyama

National Hospital Organization Chibahigashi National Hospital, Chiba, Not set

Kyushu University Hospital, Fukuoka, Not set

Fukushima Medical University, Fukushima, Not set

Gifu University Hospital, Gifu, Not set

Nagasaki University Hospital, Nagasaki, Not set

Niigata University Medical & Dental Hospital, Niigata, Not set

Okayama University Hospital, Okayama, Not set

Osaka Metropolitan University Hospital, Osaka, Not set

St. Luke's International Hospital, Tokyo, Not set

Keio university hospital, Tokyo, Not set

Wakayama Medical University Hospital, Wakayama, Not set

CIMAB SA de CV, Torreón, Coahuila

Local Institution - 0015, Cdmx, Distrito Federal

RM Pharma Specialists, Mexico city, Distrito Federal

CAIMED Investigacion en Salud, Mexico City, Distrito Federal

Centro de Investigacion Farmacologica del Bajio SC, Leon, Guanajuato

Boca Clinical Trials Mexico S.C., Guadajalara, Jalisco

Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V., Zapopan, Jalisco

Local Institution - 0010, Cuernavaca, Morelos

Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo LEON

Local Institution - 0096, Chihuahua, Not set

IMACEN S.A de C.V., Chihuahua, Not set

Oaxaca Site Management Organization, Oaxaca, Not set

Local Institution - 0100, Lima, Not set

Instituto Peruano del Hueso y la Articulación, Lima, Not set

ACQ Medic SAC - Centro de Investigación Clinica Inmunoreumatología, Lima, Not set

Local Institution - 0093, Lima, Not set

Clinica San Juan Bautista, Lima, Not set

Clinica Medica Cayetano Heredia, Lima, Not set

Local Institution - 0218, Wroclaw, Dolnośląskie

Zespół Poradni Specjalistycznych Reumed Filia nr 1 Wallenroda, Lublin, Lubelskie

Centrum Medyczne Reuma Park, Warszawa, Mazowieckie

Synexus Polska Sp. z o.o. Oddzial w Warszawie, Warszawa, Mazowieckie

Futuremeds Targowek, Warszawa, Mazowieckie

Pratia MCM Krakow, Kraków, Małopolskie

Local Institution - 0016, Elbląg, Warmińsko-mazurskie

Ortopedyczno-Rehabilitacyjny Szpital Kliniczny UM w Poznaniu, Poznan, Wielkopolskie

Centrum Wsparcia Badań Klinicznych Pomorskiego Uniwersytetu Medycznego w Szczecinie, Szczecin, Not set

MICS Centrum Medyczne Warszawa, Warszawa, Not set

Local Institution - 0031, Wroclaw, Not set

SOMED CR, Lodz, Łódzkie

M2M Med, Chorzów, Śląskie

Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisbon, Lisboa

Unidade Local De Saude De Gaia/Espinho E.P.E., Vila Nova de Gaia, Porto

Instituto Portugues de Reumatologia, Lisbon, Not set

Hospital Professor Doutor Fernando Fonseca, Lisbon, Not set

Local Institution - 0240, Caguas, Not set

Latin Clinical Trial Center, San Juan, Not set

Singapore General Hospital, Singapore, Not set

Local Institution - 0127, Singapore, Not set

Hospital de Mérida, Mérida, Badajoz

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]

Hospital Universitario Marqués de Valdecilla, Santander, Cantabria

Hospital Universitario Reina Sofia, Cordoba, Madrid

Osi Bilbao-Basurto, Bilbo, País Vasco

Local Institution - 0055, Vitoria-Gasteiz, País Vasco

Hospital Quironsalud Infanta Luisa, Sevilla, Not set

Hospital Universitario Rio Hortega, Valladolid, Not set

Hospital Universitari i Politecnic La Fe, València, Not set

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist, Kaohsiung

Chung Shan Medical University Hospital, Taichung City, Taichung

China Medical University Hospital, Taichung, Not set

Taichung Veterans General Hospital, Taichung, Not set

Chi Mei Medical Center, Tainan City, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Local Institution - 0207, Bangkok, Krung Thep Maha Nakhon

Ramathibodi Hospital, Bangkok, Krung Thep Maha Nakhon

Faculty of Medicine Siriraj Hospital, Bangkok, Krung Thep Maha Nakhon

Hacettepe Universite Hastaneleri, Ankara, Not set

Akdeniz Universitesi Hastanesi, Antalya, Not set

NCR International Hospital, Gaziantep, Not set

Local Institution - 0170, Istanbul, Not set

Royal Free Hospital, London, England

Local Institution - 0236, Larbert, Falkirk

King's College Hospital, London, Greater London

Guy's & St Thomas' NHS Foundation Trust, London, London, City Of

Local Institution - 0168, Central Middlesbrough, Middlesbrough

Local Institution - 0092, Bradford, Not set

Oxford University Hospitals - Nuffield Orthopaedic Centre, Oxford, Not set

Conditions: Systemic Lupus Erythematosus

Learn More ›

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

NCT06023641

Recruiting

This is a phase II study to determine safety and efficacy of combining liposomal irinotecan with vincristine alternating with VAC in intermediate-risk patients, liposomal irinotecan with temozolomide and vincristine alternating with VAC in high-risk patients and the chemotherapy combinations when given with concomitant radiation therapy in intermediate and high risk patients. Primary Objective * Estimate event-free survival for intermediate-risk participants treated with VAC and vincristine an... Read More

Gender:

ALL

Ages:

22 years and below

Trial Updated:

08/18/2025

Locations: Stanford University, Palo Alto, California +2 locations

Conditions: Rhabdomyosarcoma

Learn More ›

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

NCT05935384

Recruiting

The purpose of SIBYL is to generate clinical validity data for the ability of a future version of Guardant360 developed by Guardant Health to measure response to systemic therapy in patients with unresectable advanced solid tumors. It is necessary to collect clinical data points and treatment outcomes in order to demonstrate clinical validity for longitudinal monitoring with ctDNA and correlation of ctDNA dynamics with therapeutic response, as evaluated by standard methods, including RECIST 1.1... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: Orchard Healthcare Research Inc., Skokie, Illinois

Conditions: Non-small Cell Lung Cancer, Colorectal Cancer, Breast Cancer

Learn More ›

Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)

NCT05945355

Recruiting

This is single-center cross-sectional mechanistic study in lean and obese children with moderate-severe asthma, followed by a randomized, SHAM-controlled trial of Inspiratory Training (IT). The primary outcome is to describe the contributions of inspiratory muscle dysfunction (IMD) and Small Airway Dysfunction (SAD) to obesity-related versus non-obesity-related asthma. The study will involve training (IT) for 8 weeks at three intensity levels (SHAM, low and high). Target dose: 150 inspirations t... Read More

Gender:

ALL

Ages:

Between 6 years and 17 years

Trial Updated:

08/18/2025

Locations: Duke Health Center Creekstone, Durham, North Carolina +1 locations

Conditions: Asthma in Children, Obesity, Pediatric Obesity, Pediatric Asthma

Learn More ›

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

NCT05969860

Recruiting

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Currently most drug-related cancer care is conducted in infusion centers or specialty hospitals, where patients spend many hours a day isolated from family, friends, and familiar surroundings. This separation adds to the physical, emotional, social, and... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: Mayo Clinic in Florida, Jacksonville, Florida +1 locations

Conditions: Advanced Malignant Solid Neoplasm, Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, Advanced Bladder Carcinoma, Advanced Breast Carcinoma, Advanced Carcinoid Tumor, Advanced Cervical Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastric Carcinoma, Advanced Glioblastoma, Advanced Head and Neck Carcinoma, Advanced HER2 Positive Breast Carcinoma, Advanced Lung Carcinoma, Advanced Lung Small Cell Carcinoma, Advanced Malignant Germ Cell Tumor, Advanced Neuroendocrine Carcinoma, Advanced Ovarian Carcinoma, Advanced Pancreatic Carcinoma, Advanced Prostate Carcinoma, Advanced Prostate Small Cell Neuroendocrine Carcinoma, Hematopoietic and Lymphoid System Neoplasm, Multiple Myeloma, Myelodysplastic Syndrome, Advanced Basal Cell Carcinoma, Advanced Cholangiocarcinoma, Advanced Endometrial Carcinoma, Advanced Esophageal Carcinoma, Advanced Fallopian Tube Carcinoma, Advanced Hepatocellular Carcinoma, Advanced Liver Carcinoma, Advanced Lymphoma, Advanced Malignant Testicular Neoplasm, Advanced Melanoma, Advanced Merkel Cell Carcinoma, Advanced Penile Carcinoma, Advanced Primary Malignant Central Nervous System Neoplasm, Advanced Renal Cell Carcinoma, Advanced Sarcoma, Advanced Skin Squamous Cell Carcinoma, Advanced Urethral Carcinoma, Advanced Vaginal Carcinoma, Advanced Vulvar Carcinoma, Appendix Carcinoma

Learn More ›